ReviewGE Portuguese journal of gastroenterology2025

Rifaximin as a Therapeutic Ally in the Modulation of Dysbiosis: A Narrative Review of Its Applicability in Gastrointestinal Disorders.

Joana Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.